Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction - Top-Institutions - MDSpire

Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction

  • By

  • Yanlong Zhao

  • Haodong Jiang

  • Yuanyuan Zhao

  • Shuai Wang

  • Qicheng Yu

  • Jing Zeng

  • Shan Xie

  • Jiatong Li

  • Zhi Liu

  • July 2, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Beijing tertiary hospital
    Beijing tertiary hospital

    Beijing, Beijing

    Key Differentiators

    • Cardiology

  • #2

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, Massachusetts

    Key Differentiators

    • Cardiology

  • #3

    Affiliated Hospital of North Sichuan Medical College
    Affiliated Hospital of North Sichuan Medical College

    Nanchong, Sichuan

    Key Differentiators

    • Cardiology

Original Source(s)

Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction

  • by Yanlong Zhao, Haodong Jiang, Yuanyuan Zhao, Shuai Wang, Qicheng Yu, Jing Zeng, Shan Xie, Jiatong Li, Zhi Liu

  • July 2, 2026

Related Content

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

Development and validation of a risk stratification model for cardiovascular disease in patients with radiographic axial spondyloarthritis (r-axSpA): a retrospective study

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.